Industry Impacts Of COVID-19: Are Vaccine Mandates A Legal Solution?
The coronavirus pandemic is still raging but it is clear that higher vaccination rates worldwide will help the life sciences sector return to a semblance of normality. Lincoln Tsang, Julie Kvedar, and William Radcliffe of Ropes & Gray LLP consider the impact of the COVID-19 pandemic on the industry and the legal issues raised by mandatory vaccination in certain key geographical regions.
You may also be interested in...
Delaware district judge rules against AstraZeneca’s claim the IRA violates its due process rights, echoing findings made by Ohio district judge in Chamber of Commerce’s suit. Only other IRA ruling to date dismissed PhRMA’s complaint on procedural grounds without addressing the merits.
Lumicell’s Cancer Imaging Drug Faces Clinical Meaningfulness, Anaphylaxis Risk Questions At FDA Panel
US FDA advisory committee briefing documents say drug-device combo Lumisight (pegulicianine) is effective at picking up cancer but it is not clear whether that translates to patient benefit.
This week, NIST published a new version of its international cybersecurity standard; SeaStar Medical’s kidney device got an HDE; and the FDA announced safety issues for DT MedTech LLC, operating room tables, and GE incubators.